Chemours Names Interim CEO and CFO Amid Leadership Changes

TL;DR

Chemours CEO Mark Vergnano out, Denise Dignam interim CEO, Alisha Strohmeyer interim CFO.

AI Summary

The Chemours Company announced on July 23, 2024, changes in its executive team. Mark P. Vergnano is stepping down as Chief Executive Officer, and Denise L. Dignam will assume the role of Interim Chief Executive Officer. Additionally, Alisha L. Strohmeyer has been appointed Interim Chief Financial Officer, succeeding Jonathan L. F. Law. These changes are effective immediately.

Why It Matters

This leadership transition at The Chemours Company could signal strategic shifts or operational adjustments as the company navigates its current market conditions.

Risk Assessment

Risk Level: medium — Leadership changes, especially at the CEO and CFO level, can introduce uncertainty regarding future strategy and operational stability.

Key Players & Entities

• The Chemours Company (company) — Registrant
• Mark P. Vergnano (person) — Outgoing Chief Executive Officer
• Denise L. Dignam (person) — Interim Chief Executive Officer
• Alisha L. Strohmeyer (person) — Interim Chief Financial Officer
• Jonathan L. F. Law (person) — Outgoing Chief Financial Officer
• July 23, 2024 (date) — Effective date of changes

FAQ

From the Filing

0000950170-24-086564.txt : 20240725 0000950170-24-086564.hdr.sgml : 20240725 20240725163512 ACCESSION NUMBER: 0000950170-24-086564 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20240723 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20240725 DATE AS OF CHANGE: 20240725 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Chemours Co CENTRAL INDEX KEY: 0001627223 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 464845564 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36794 FILM NUMBER: 241142532 BUSINESS ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 302 773 1000 MAIL ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 FORMER COMPANY: FORMER CONFORMED NAME: Chemours Company, LLC DATE OF NAME CHANGE: 20141205 8-K 1 cc-20240723.htm 8-K 8-K false 0001627223 0001627223 2024-07-23 2024-07-23     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   FORM 8-K   CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   July 23, 2024 Date of Report (Date of Earliest Event Reported)   The Chemours Company (Exact Name of Registrant as Specified in Its Charter)   Delaware   001-36794   46-4845564 (State or Other Jurisdiction   (Commission   (I.R.S. Employer Of Incorporation)   File Number)   Identification No.)   1007 Market Street Wilmington , Delaware 19801 (Address of principal executive offices)   Registrant’s telephone number, including area code: (302) 773-1000   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of Each Class   Trading Symbol(s)   Name of Exchange on Which Registered Common Stock ($0.01 par value)   CC   New York Stock Exchange   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company   ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐           Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On July 23, 2024, David A. Will was appointed as Controller and Chief Accounting Officer (principal accounting officer) of The Chemours Company (the “Company”) effective as of August 12, 2024. Shane Hostetter, the Company’s Chief Financial Officer, will continue to serve as principal accounting officer until the effective date of Mr. Will’s appointment. Mr. Will, age 40, has served as Interim Chief Financial Officer of Copeland LP since February 2024 and as Vice President,